MedMen Enterprises Inc (MMNFQ)
0.0000
USD |
OTCM |
Jun 27, 13:30
MedMen Enterprises Max Drawdown (5Y): 100.00% for May 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
May 31, 2024 | 100.00% |
April 30, 2024 | 100.00% |
March 31, 2024 | 100.00% |
February 29, 2024 | 100.00% |
January 31, 2024 | 100.00% |
December 31, 2023 | 99.80% |
November 30, 2023 | 99.80% |
October 31, 2023 | 99.80% |
September 30, 2023 | 99.80% |
August 31, 2023 | 99.80% |
July 31, 2023 | 99.80% |
June 30, 2023 | 99.80% |
May 31, 2023 | 99.80% |
April 30, 2023 | 99.80% |
March 31, 2023 | 99.80% |
February 28, 2023 | 99.80% |
January 31, 2023 | 99.80% |
December 31, 2022 | 99.80% |
November 30, 2022 | 99.57% |
October 31, 2022 | 99.50% |
September 30, 2022 | 99.44% |
August 31, 2022 | 99.22% |
July 31, 2022 | 99.22% |
June 30, 2022 | 99.17% |
May 31, 2022 | 98.81% |
Date | Value |
---|---|
April 30, 2022 | 98.56% |
March 31, 2022 | 98.56% |
February 28, 2022 | 98.56% |
January 31, 2022 | 98.56% |
December 31, 2021 | 98.42% |
November 30, 2021 | 98.42% |
October 31, 2021 | 98.42% |
September 30, 2021 | 98.42% |
August 31, 2021 | 98.42% |
July 31, 2021 | 98.42% |
June 30, 2021 | 98.42% |
May 31, 2021 | 98.42% |
April 30, 2021 | 98.42% |
March 31, 2021 | 98.42% |
February 28, 2021 | 98.42% |
January 31, 2021 | 98.42% |
December 31, 2020 | 98.42% |
November 30, 2020 | 98.42% |
October 31, 2020 | 98.42% |
September 30, 2020 | 98.42% |
August 31, 2020 | 98.42% |
July 31, 2020 | 98.42% |
June 30, 2020 | 98.42% |
May 31, 2020 | 98.42% |
April 30, 2020 | 98.42% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
72.22%
Minimum
Jun 2019
100.00%
Maximum
Feb 2024
96.90%
Average
98.42%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
NovaBay Pharmaceuticals Inc | 99.91% |
Palatin Technologies Inc | 96.46% |
iBio Inc | 99.97% |
Theriva Biologics Inc | 99.81% |
Oragenics Inc | 98.92% |